A 3-month topical application of clobetasol propionate ( CP ) represents the recommended and accepted first-line treatment for vulvar lichen sclerosus ( VLS ) ; however , to date , no randomized controlled trials have compared the efficacy and safety of CP with other topical corticosteroids .